GenScript Receives $213.8M Payment from LaNova for PD-1 Antibody License
CompanyDeals

GenScript Receives $213.8M Payment from LaNova for PD-1 Antibody License

UCB's Fenfluramine Shows Positive Results in Phase III GEMZ Study for CDKL5 Deficiency Disorder
CompanyDrug

UCB’s Fenfluramine Shows Positive Results in Phase III GEMZ Study for CDKL5 Deficiency Disorder

Sunshine Lake Pharma Lists on HKEX via Introduction Method
CompanyDeals

Sunshine Lake Pharma Lists on HKEX via Introduction Method

MGI Tech Partners with Italy's Negedia to Advance Genomic Sequencing and Spatial Transcriptomics
CompanyDeals

MGI Tech Partners with Italy’s Negedia to Advance Genomic Sequencing and Spatial Transcriptomics

China Proposes Healthcare Security Law to Strengthen Medical Insurance System
Policy / Regulatory

China Proposes Healthcare Security Law to Strengthen Medical Insurance System

QuantumPharm and Pfizer Expand Collaboration on Advanced Molecular Simulation Platform
CompanyDeals

QuantumPharm and Pfizer Expand Collaboration on Advanced Molecular Simulation Platform

BlissBio Inc. Files for Hong Kong IPO to Advance Oncology-Focused ADC Pipeline
CompanyDeals

BlissBio Inc. Files for Hong Kong IPO to Advance Oncology-Focused ADC Pipeline

FDA Removes REMS Requirements for BCMA- and CD19-Targeted CAR-T Therapies
Policy / Regulatory

FDA Removes REMS Requirements for BCMA- and CD19-Targeted CAR-T Therapies

ProFound Therapeutics and Novartis Forge Four-Year Partnership for Cardiovascular Drug Targets
CompanyDeals

ProFound Therapeutics and Novartis Forge Four-Year Partnership for Cardiovascular Drug Targets

Diagens Biotech's AI Imaging Platform iMedImage Makes Hong Kong IPO Debut
CompanyDeals

Diagens Biotech’s AI Imaging Platform iMedImage Makes Hong Kong IPO Debut

Pfizer's Emblaveo Approved by China's NMPA for Complex Infections
CompanyDrug

Pfizer’s Emblaveo Approved by China’s NMPA for Complex Infections

Gilead's Lenacapavir Approved in Hainan for HIV-1 Pre-Exposure Prophylaxis
CompanyDrug

Gilead’s Lenacapavir Approved in Hainan for HIV-1 Pre-Exposure Prophylaxis